Conventional myosin II is an essential protein for cytokinesis, capping of cell surface receptors, and development of Dictyostelium cells. Myosin II also plays an important role in the polarization and movement of cells. All conventional myosins are double-headed molecules but the significance of this structure is not understood since singleheaded myosin II can produce movement and force in vitro. We found that expression of the tail portion of myosin II in Dictyostelium led to the formation of single-headed myosin II in vivo. The resultant cells contain an approximately equal ratio of double-and single-headed myosin II molecules. Surprisingly, these cells were completely blocked in cytokinesis and capping of concanavalin A receptors although development into fruiting bodies was not impaired. We found that this phenotype is not due to defects in myosin light chain phosphorylation. These results show that single-headed myosin II cannot function properly in vivo and that it acts as a dominant negative mutation for myosin II function. These results suggest the possibility that cooperativity of myosin II heads is critical for force production in vivo.
Why does myosin II have two heads? All conventional myosins from muscle to nonmuscle sources are two-headed molecules that assemble into thick filaments. However, the functional significance of this dimeric structure is not clear. One possibility is that the two heads act cooperatively. It is known, for example, that the affinity of single-headed myosin for actin is about an order of magnitude lower than that of double-headed myosin (1) . However, in vitro motility assays have shown that single-headed myosin II molecules (2, 3) and single isolated myosin heads (4, 5) are able to produce force and movement, indicating that any cooperative aspect is not essential for function. An alternate possibility is that the dimeric structure of myosin is required solely to generate an a-helical coiled-coil tail. This structure of the elongated myosin tail is known to be essential for the formation of bipolar filaments that harness the activity of multiple heads into a single motile unit. If this scenario were true, the second head of myosin may be unimportant for function. The fact that single-headed myosin II molecules are functionally equivalent to double-headed ones in vitro supports this hypothesis (2, 3) . However, all these studies have been carried out in vitro since, until now, there has been no available test for the function of single-headed myosin II in vivo.
In this paper, we explore the functional significance of the two heads of myosin by using Dictyostelium discoideum. Previous studies have shown that myosin II is essential for several motile processes in this organism. Mutants defective in the myosin II heavy and light chains display a complete block in cytokinesis, capping of cell surface receptors, and development (6) (7) (8) (9) . In addition, the lack of myosin heavy chain (MHC) leads to severe defects in cell motility (10, 11) .
Our initial goal in the experiments described here was to test the importance of the density of myosin heads along a myosin thick filament, by overexpressing the tail segment (rod) of myosin II. Myosin rods and myosin can readily coassemble into the same thick filament, and the hybrid filaments can produce force in vitro (3) . In addition to rods, the expressed tail peptide could form hybrid dimers with the endogenous MHC peptide forming single-headed myosin II. This molecule would contain a normal coiled-coil tail with a single myosin head. Both rods and single-headed myosin II should reduce the density of myosin heads on thick filaments. Surprisingly, we found that the expressed tail peptide assembled primarily into hybrid single-headed myosin II. The phenotype of the cells containing this hybrid molecule indicates that the two heads of myosin are indeed required for proper function in vivo.
MATERIALS AND METHODS
Cell Culture Growth, Transformation, and Test for Growth in Suspension. Conditions for growth of cultures and transformation of D. discoideum by electroporation have been described (12) . Clonal transformants were obtained by selection in HL5 medium containing G418 (10 ,g/ml). All cell lines were maintained on Petri dishes in the same medium. To test for their ability to grow in suspension, each cell line was placed in an Erlenmeyer flask on an orbital shaker at 240 rpm and the titer was monitored for several days.
Design of Expression Vectors. To express myosin tail fragments in Dictyostelium, we used the plasmid pAD80HA, which is a modified version of plasmid pBS18 (kindly provided by Richard Firtel, University of California, San Diego). This vector contains a G418-selectable marker under the control of the actin-6 promoter and the actin-15 terminator. We modified this vector to express epitope-tagged proteins under the control of the actin-15 promoter and the SP70 terminator. This vector, pAD80HA, encodes an initiation methionine followed by the sequence recognized by the monoclonal antibody 12CA5 (YPYDVPDYA). The epitope tag is followed by restriction sites for Nco I, Kpn I, EcoRI, Bgl II, HindIll, and Kpn I. These sites were incorporated for the cloning and expression of specific MHC fragments.
Plasmid pAD80HA-ROD was obtained by cloning a 4.2-kb Nco I-Sma I fragment from pBgl4.5 (13) into the Nco I-Eco-RI(blunt) sites of pAD80HA. This plasmid contains the entire myosin tail coding region (aa 809-2116, Fig. 1 ) and 260 bp of 3' noncoding region. The predicted molecular mass of this fragment is 152 kDa. To obtain plasmid pAD80HA-S2, we simply removed from pAD80HA-ROD a 2.4-kb Kpn I fragment encompassing the light meromyosin portion and 3' noncoding region. Therefore, plasmid pAD80HA-S2 encodes a myosin tail peptide from aa 809 to aa 1529 of the MHC Abbreviations: MHC, myosin heavy chain; RMLC, regulatory myosin light chain. *To whom reprint requests should be addressed.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 15 ,000 rpm in a SS-34 rotor for 30 min at 4°C. The supernatant containing myosin (0.5 ml) was loaded on a Superose-6 10/30 column. Myosin was eluted in an -3-ml peak shortly behind the void volume. There was no separation of the different myosin species across this peak. The pooled fractions were concentrated to 0.5 ml on a Centricon-30, and 0.2 ml was loaded on a 5-ml gradient of 15-40% glycerol in 0.5 M ammonium bicarbonate. Gradients were centrifuged in the Beckman SW 50.1 rotor at 50,000 rpm, 20°C for 15 hr; 0.2-ml fractions were collected and analyzed by SDS/PAGE on Coomassie blue-stained gels. Comparison of the peak fractions to standard vroteins sedimented in a separate gradient indicated approximate sedimentation coefficients of 5.3 S, 4.4 S, and 3.1 S for fractions 7, 9, and 11, respectively.
Light-Chain Phosphorylation Assay. Cells (3 ml at 1 x 106 cells per ml) were plated onto duplicate 60-mm tissue culture plates and allowed to attach. Cells were then washed with Mes wash buffer (20 mM Mes/0.2 mM CaCl2/2 mM MgSO4, pH 6.8) and kept in 2.5 ml of the same buffer. Con A type IV (Sigma) was added to one of the plates, at 30 A'g/ml, and incubated for 10 min. The cells were then released from the plates by pipetting up and down, and 1 ml was transferred to a tube containing 100 ,l of 100% (wt/vol) trichloroacetic acid. The precipitated proteins were solubilized with 25 ,ul of 2x urea gel sample buffer, separated on a urea gel (15) , and examined by Western blot analysis using a monoclonal antibody directed against the regulatory myosin light chain (RMLC) (antibody 1A2, kindly provided by Rex Chisholm, Northwestern University).
RESULTS
Expression of Myosin Tail Fragments in Dictyostelium. We designed Dictyostelium expression vectors for the production of tail segments of myosin II (Fig. 1) . One vector, pAD80HA-ROD, encodes the entire myosin tail portion of the Dictyostelium mhcA gene. This portion of the MHC contains the assembly and regulatory domains that mediate the proper assembly of myosin filaments in the cell (16, 17) . The expressed tail peptide should be able to form myosin rods or singleheaded myosin II and incorporate into myosin filaments. As a control, we designed a vector, pAD80HA-S2, for the expression of myosin S2 fragments. This myosin fragment lacks the assembly domain and, therefore, would not incorporate into myosin filaments.
Both vectors were introduced into Dictyostelium Ax3 cells. Clonal cell lines were isolated (ROD cells and S2 cells) that expressed the appropriate myosin fragments (Fig. 2) . We determined by scanning gel densitometry that both fragments were expressed at levels close to those of the endogenous MHC (data not shown). Furthermore, the expression of either (7, 9) . We assayed for cytokinesis by placing each cell line in suspension cultures and monitoring their growth. We found that the wild-type and S2 cells grew at similar rates, whereas the ROD cells failed to grow under the same conditions (data not shown). This failure of the ROD cells to grow resulted from a deficiency in cytokinesis. These cells displayed a remarkable accumulation of nuclei and became very large in suspension conditions (Fig. 3B) , whereas neither the wild-type cells (Fig.  3A) nor the S2 cells (data not shown) became large or multinucleate. When the same cell lines were treated with Con A, the wild-type (Fig. 3C ) and S2 cells (data not shown) concentrated the bound ligand into a polar cap after a few minutes. However, even 30 min after treatment, the ROD cells did not produce caps (Fig. 3D) . These experiments suggest that the expression of the myosin tail peptide interferes with normal myosin II function.
The ROD cells did retain some myosin II function. When placed in starvation conditions, the ROD cells completed the Dictyostelium developmental cycle and formed fully differentiated fruiting bodies in a time frame similar to that of wild-type and S2 cells (data not shown). Upon close inspection, however, we noticed that the fruiting bodies formed by the ROD cells were slightly smaller and more numerous than those from wild-type and S2 cells (data not shown). Therefore, the disruption of myosin II function by the myosin tail peptide seems to be most potent during cytokinesis and capping.
These experiments demonstrate that, despite having a full complement of MHC, the ROD cells are deficient in two important myosin II functions. One possible explanation is that the tail peptide causes the redistribution of myosin II to an inappropriate intracellular location. However, both indirect immunofluorescence microscopy of ROD cells stained with an anti-myosin antibody and analysis of the ROD cells by thinsection electron microscopy gave results that were indistinguishable from wild-type cells (data not shown). (Fig. 4, lane  1) , whereas the ROD cells contain two major and one minor species (Fig. 4, lane 2) . The largest species consist of doubleheaded myosin II since it comigrates with the wild-type species. The smallest species consists of myosin rods. This species is found in very small concentrations in these cells and can only be detected on long exposures of the blot. To illustrate the migration of this species on the native gel, we purified myosin rods to homogeneity and loaded them on the same gel (Fig. 4, lane 3) . The intermediate species, therefore, presumably represents single-headed molecules since it migrates between the doubleheaded and zero-headed molecules.
To further characterize these different myosin II species, we analyzed them by zone 8247 and by SDS/PAGE. Double-headed myosin II from wild-type cells was resolved as a single discrete peak in this gradiept (Fig.   SA, fraction 7) . In contrast, myosin II from the ROD cells was spread over several fractions. The heaviest fractions sedimented in the same position as the wild-type double-headed myosin II and contained only the full-length MHC (Fig. 5B,  fractions 6 and 7) . The intermediate fractions contained both MHC and myosin tail peptide in approximately equal amounts (Fig. 5B, fractions 8 and 9 ), a ratio consistent with a singleheaded myosin II. Finally, the lightest fractions contained only the tail peptide (Fig. SB, fractions 10 and 11 ) and, therefore, correspond to myosin rods without heads.
To confirm the identity of the different myosin II species, we analyzed the proteins from these fractions by rotaryshadowing electron microscopy. We found that fractions 7 and 10 contained predominantly double-headed myosin and myosin rod, respectively (Fig. 6) . The intermediate fraction 9 contained a few double-headed myosins and rods, but the majority of myosin molecules (>80%) appeared to be singleheaded. Therefore, based on the results of native gel electrophoresis, gradient sedimentation, and the identification of molecules in the electron microscope, we conclude that double-and single-headed myosin II and rods with no heads are present in the mutant cells.
Our results indicate that the expression of myosin tail peptide in Dictyostelium cells leads to the formation of singleheaded myosin II. From densitometric scans of Western blots of native gels, we calculated an approximately equal ratio of double-and single-headed myosin II and only trace amounts of rod molecules without heads (data not shown). To estimate the amount of rod molecules in the mutant cells, we calculated the yield of purified rod from the boiled extracts. These estimates indicated that the amount of rod molecules is less than 10% the amount of single-headed myosin II. The actual amount of rod molecules may be even smaller since rods can be easily produced in the cell extracts by proteolysis of single-headed myosin II. We have observed, for example, that the myosin preparations from ROD cells (Fig. 5B) are more susceptible to proteolysis than those from wild-type cells (Fig.  5A) . Therefore, we think it is likely that the phenotypic defects observed in the ROD cells are a direct result of the presence of single-headed myosin II in these cells. Consequently, singleheaded myosin II acts as a dominant negative mutation for myosin function.
Phosphorylation of the RMLC Is Normal in the ROD Mutant. One possible consequence of the presence of singleheaded myosin in the ROD mutants is the disruption of myosin light chain phosphorylation. If phosphorylation of the RMLC is a cooperative event, then the lack of one head may disturb this process. To determine whether this type of cooperativity is responsible for the phenotype of the ROD cells, we analyzed the phosphorylation of the RMLCs in these cells. Dictyostelium wild-type cells phosphorylate the RMLC by a specific RMLC kinase in response to treatment with Con A (J. L. Smith, L. A. Silveira, and J. A. Spudich, personal communication) (Fig. 7,  lanes 1 and 2) . When the ROD mutant cells were treated with FIG. 7. RMLC is phosphorylated in both wild-type and ROD mutant cells after Con A treatment. The phosphorylation state of the RMLC was analyzed by separation on urea gels and detection by Western blot analysis. In untreated wild-type (wt) cells, most of the RMLC is found in the unphosphorylated state (lane 1). However, after a brief exposure to Con A (10 min), essentially all of the RMLC is converted to the phosphorylated form (lane 2). The same response was also observed for the ROD mutant cells (lanes 3 and 4) .
Con A, the RMLC was phosphorylated normally (Fig. 7, lanes  3 and 4) . Thus, the regulation of myosin II by phosphorylation of the RMLC is not affected by the presence of single-headed myosin II.
DISCUSSION
We have shown herein that the in vivo expression of the myosin tail peptide in a wild-type background leads to the formation of single-headed myosin II and causes the loss of myosin function in Dictyostelium cells. This dominant negative effect is specific for the tail peptide since the expression of the myosin S2 peptide produces no detectable consequences. We find that most of the expressed tail peptide is associated with a fulllength MHC peptide forming single-headed myosin II molecules. Therefore, the dominant negative effect observed in these mutant cells is associated with the presence of singleheaded myosin II Although nothing is known about the mechanisms of coiledcoil formation in vivo, it is likely that the dimerization of two MHC peptides occurs post-translationally. This hypothesis is supported by the presence of myosin heterodimeric molecules in rat cardiac tissue and smooth muscle (19, 20) . Our results also support this hypothesis since we find heterodimeric singleheaded myosin molecules. However, it is not clear why the ROD mutant cells contain very few rod peptide homodimers. We do not think that this bias from a random distribution is caused by instability of the rod molecules within the cell. Myosin rods have been expressed in a Dictyostelium myosin null cell line without any obvious signs of instability (T. Egelhoff A more attractive possibility suggested by our results is that an important cooperative aspect of myosin II function has been affected in vivo. In smooth muscle, for example, the activation of myosin II by light chain phosphorylation is a cooperative phenomenon along a myosin filament (24) . It is possible that the phosphorylation of the RMLC in the single-headed myosin may not be as efficient as in a double-headed molecule. Furthermore, the incorporation of single-headed myosin into filaments may disturb the phosphorylation of the doubleheaded molecules in the same filament. We believe this is an unlikely possibility since we have found that phosphorylation of the RMLC in the ROD mutant cells is normal in response to stimulation with Con A. Another cooperative function that could be perturbed in the mutant cells is the cooperative contribution of myosin heads to force production. It is known that single-headed myosin II binds to actin much more weakly than double-headed myosin under certain conditions (25) . Although the absence of one head does not detract from motility when myosins are bound randomly to glass, the cooperative or sequential binding of two heads may play a crucial role for motility along a myosin filament in vivo. It is possible that myosin heads need to be precisely distributed along the surface of the filament to achieve force production in vivo. The absence of some heads along the filament may, therefore, disturb the entire process.
Finally, it is possible that the single-headed myosin is no longer regulated by phosphorylation in vivo. Recent studies have shown that single-headed myosin from smooth muscle is fully active independently of the phosphorylation state of the remaining RMLC (26) . If myosin function in vivo requires the ability to "turn off' myosin molecules by dephosphorylation, then the presence of unregulated single-headed molecules may severely disrupt myosin function in the cell. This hypothesis may also explain the results obtained with a mutation in the phosphorylation site of the Dictyostelium RMLC (15) . When Ser-13 was replaced by Ala, the resultant myosin displayed only a basal ATPase activity similar to unphosphorylated Dictyostelium myosin. Surprisingly, cells carrying this mutation have a completely normal phenotype, indicating that activation of myosin II by phosphorylation is not essential for myosin function in vivo. However, if the important aspect for myosin function is to reduce its activity by dephosphorylation, then the mutation described above would be predicted to have no major effect in vivo. On the other hand, a Ser-13 --Asp change may mimic the phosphorylated RMLC and result in a constitutively active myosin molecule. Our results would suggest that this mutation may have a domninant negative phenotype.
